HEADER ANTIBIOTIC 08-APR-22 7UMW TITLE CRYSTAL STRUCTURE OF E. COLI FABI IN COMPLEX WITH NAD AND FABIMYCIN TITLE 2 ((S,E)-3-(7-AMINO-8-OXO-6,7,8,9-TETRAHYDRO-5H-PYRIDO[2,3-B]AZEPIN-3- TITLE 3 YL)-N-METHYL-N-((3-METHYLBENZOFURAN-2-YL)METHYL)ACRYLAMIDE) COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE [NADH] FABI; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ENR,NADH-DEPENDENT ENOYL-ACP REDUCTASE; COMPND 5 EC: 1.3.1.9; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI STR. K-12 SUBSTR. MG1655; SOURCE 3 ORGANISM_TAXID: 511145; SOURCE 4 GENE: FABI; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS ENOYL REDUCTASE, FABI, ANTIMICROBIAL RESISTANCE, ANTIBIOTIC EXPDTA X-RAY DIFFRACTION AUTHOR B.HAJIAN REVDAT 4 25-OCT-23 7UMW 1 REMARK REVDAT 3 16-AUG-23 7UMW 1 SOURCE REVDAT 2 15-FEB-23 7UMW 1 JRNL REVDAT 1 14-DEC-22 7UMW 0 JRNL AUTH E.N.PARKER,B.N.CAIN,B.HAJIAN,R.J.ULRICH,E.J.GEDDES,S.BARKHO, JRNL AUTH 2 H.Y.LEE,J.D.WILLIAMS,M.RAYNOR,D.CARIDHA,A.ZAINO,J.M.ROHDE, JRNL AUTH 3 M.ZAK,M.SHEKHAR,K.A.MUNOZ,K.M.RZASA,E.R.TEMPLE,D.HUNT,X.JIN, JRNL AUTH 4 C.VUONG,K.PANNONE,A.M.KELLY,M.P.MULLIGAN,K.K.LEE,G.W.LAU, JRNL AUTH 5 D.T.HUNG,P.J.HERGENROTHER JRNL TITL AN ITERATIVE APPROACH GUIDES DISCOVERY OF THE FABI INHIBITOR JRNL TITL 2 FABIMYCIN, A LATE-STAGE ANTIBIOTIC CANDIDATE WITH IN VIVO JRNL TITL 3 EFFICACY AGAINST DRUG-RESISTANT GRAM-NEGATIVE INFECTIONS JRNL REF ACS CENT.SCI. V. 8 1362 2022 JRNL REFN ESSN 2374-7951 JRNL PMID 36188352 JRNL DOI 10.1021/ACSCENTSCI.2C00969 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH E.N.PARKER,B.N.CAIN,B.HAJIAN,R.J.ULRICH,E.J.GEDDES,S.BARKHO, REMARK 1 AUTH 2 H.Y.LEE,J.D.WILLIAMS,M.RAYNOR,D.CARIDHA,A.ZAINO,M.SHEKHAR, REMARK 1 AUTH 3 K.A.MUNOZ,K.M.RZASA,E.R.TEMPLE,D.HUNT,X.JIN,C.VUONG, REMARK 1 AUTH 4 K.PANNONE,A.M.KELLY,M.P.MULLIGAN,K.K.LEE,G.W.LAU,D.T.HUNG, REMARK 1 AUTH 5 P.J.HERGENROTHER REMARK 1 TITL AN ITERATIVE APPROACH GUIDES DISCOVERY OF THE FABI INHIBITOR REMARK 1 TITL 2 FABIMYCIN, A LATE-STAGE ANTIBIOTIC CANDIDATE WITH IN VIVO REMARK 1 TITL 3 EFFICACY AGAINST DRUG-RESISTANT GRAM-NEGATIVE INFECTIONS. REMARK 1 REF ACS CENT.SCI. V. 8 1145 2022 REMARK 1 REFN ESSN 2374-7951 REMARK 1 PMID 36032774 REMARK 1 DOI 10.1021/ACSCENTSCI.2C00598 REMARK 2 REMARK 2 RESOLUTION. 1.54 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19.2_4158 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.54 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 58.06 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 91.7 REMARK 3 NUMBER OF REFLECTIONS : 156032 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.214 REMARK 3 R VALUE (WORKING SET) : 0.214 REMARK 3 FREE R VALUE : 0.245 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.340 REMARK 3 FREE R VALUE TEST SET COUNT : 3656 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 58.0600 - 4.5600 1.00 6403 158 0.1503 0.1461 REMARK 3 2 4.5600 - 3.6200 1.00 6368 148 0.1424 0.2037 REMARK 3 3 3.6200 - 3.1600 1.00 6426 150 0.1787 0.2196 REMARK 3 4 3.1600 - 2.8700 1.00 6386 153 0.2045 0.2406 REMARK 3 5 2.8700 - 2.6600 1.00 6376 158 0.2038 0.2223 REMARK 3 6 2.6600 - 2.5100 1.00 6387 156 0.2119 0.2303 REMARK 3 7 2.5100 - 2.3800 1.00 6423 153 0.2200 0.2147 REMARK 3 8 2.3800 - 2.2800 1.00 6364 153 0.2174 0.2590 REMARK 3 9 2.2800 - 2.1900 1.00 6393 152 0.2193 0.2569 REMARK 3 10 2.1900 - 2.1100 0.99 6402 149 0.2220 0.2381 REMARK 3 11 2.1100 - 2.0500 0.99 6312 153 0.2258 0.2980 REMARK 3 12 2.0500 - 1.9900 0.98 6237 154 0.2382 0.2383 REMARK 3 13 1.9900 - 1.9400 0.97 6193 153 0.2382 0.2943 REMARK 3 14 1.9400 - 1.8900 0.95 6066 144 0.2463 0.2795 REMARK 3 15 1.8900 - 1.8500 0.92 5913 140 0.2577 0.2872 REMARK 3 16 1.8500 - 1.8100 0.90 5776 140 0.2680 0.3189 REMARK 3 17 1.8100 - 1.7700 0.89 5687 133 0.2753 0.3650 REMARK 3 18 1.7700 - 1.7400 0.87 5570 137 0.2693 0.3275 REMARK 3 19 1.7400 - 1.7100 0.86 5505 128 0.2786 0.2787 REMARK 3 20 1.7100 - 1.6800 0.85 5403 132 0.2760 0.3432 REMARK 3 21 1.6800 - 1.6500 0.84 5360 135 0.2767 0.3096 REMARK 3 22 1.6500 - 1.6300 0.82 5227 122 0.2763 0.3165 REMARK 3 23 1.6300 - 1.6000 0.78 4942 119 0.2795 0.2746 REMARK 3 24 1.6000 - 1.5800 0.77 4970 118 0.2809 0.3042 REMARK 3 25 1.5800 - 1.5600 0.75 4742 114 0.2716 0.2873 REMARK 3 26 1.5600 - 1.5400 0.70 4545 104 0.2840 0.2948 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.211 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.476 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 11.25 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.23 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 4071 REMARK 3 ANGLE : 1.265 5532 REMARK 3 CHIRALITY : 0.066 623 REMARK 3 PLANARITY : 0.010 710 REMARK 3 DIHEDRAL : 6.463 579 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): -35.8601 35.5685 -18.7603 REMARK 3 T TENSOR REMARK 3 T11: 0.0275 T22: 0.0543 REMARK 3 T33: 0.0699 T12: 0.0290 REMARK 3 T13: -0.0039 T23: -0.0301 REMARK 3 L TENSOR REMARK 3 L11: 0.6318 L22: 1.2100 REMARK 3 L33: 1.2240 L12: 0.7044 REMARK 3 L13: 0.7093 L23: 1.0753 REMARK 3 S TENSOR REMARK 3 S11: -0.0399 S12: 0.0293 S13: -0.0092 REMARK 3 S21: 0.0094 S22: 0.0488 S23: -0.0083 REMARK 3 S31: -0.1111 S32: 0.1717 S33: 0.0487 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7UMW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-APR-22. REMARK 100 THE DEPOSITION ID IS D_1000264482. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-OCT-21 REMARK 200 TEMPERATURE (KELVIN) : 193 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS-II REMARK 200 BEAMLINE : 17-ID-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9793 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 156032 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.540 REMARK 200 RESOLUTION RANGE LOW (A) : 58.060 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.9 REMARK 200 DATA REDUNDANCY : 2.000 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.0600 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.54 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.60 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 4JQC REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.96 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.61 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM TRIS PH 7.5-8.5 0.5-1.5 M REMARK 280 SODIUM CITRATE TRIBASIC., VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 7555 Y,X,-Z+1/3 REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z+2/3 REMARK 290 10555 -Y,-X,-Z+5/6 REMARK 290 11555 -X+Y,Y,-Z+1/2 REMARK 290 12555 X,X-Y,-Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 107.89333 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 215.78667 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 161.84000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 269.73333 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 53.94667 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 107.89333 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 215.78667 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 269.73333 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 161.84000 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 53.94667 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 20100 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 30330 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -121.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 -0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 -53.94667 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 526 LIES ON A SPECIAL POSITION. REMARK 375 HOH B 505 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -3 REMARK 465 ASP A -2 REMARK 465 HIS A -1 REMARK 465 GLY A 0 REMARK 465 GLU A 260 REMARK 465 LEU A 261 REMARK 465 LYS A 262 REMARK 465 GLY B -3 REMARK 465 ASP B -2 REMARK 465 HIS B -1 REMARK 465 GLY B 0 REMARK 465 LEU B 261 REMARK 465 LYS B 262 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 7 NZ REMARK 470 LYS A 201 CG CD CE NZ REMARK 470 ARG A 204 CG CD NE CZ NH1 NH2 REMARK 470 MET B 1 CG SD CE REMARK 470 LYS B 17 CG CD CE NZ REMARK 470 LYS B 201 CG CD CE NZ REMARK 470 ARG B 204 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 260 CG CD OE1 OE2 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 VAL A 105 N CA C O CB CG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH B 535 O HOH B 542 2.18 REMARK 500 O HOH A 487 O HOH A 565 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 155 -22.74 74.64 REMARK 500 ASN A 157 -129.68 56.36 REMARK 500 VAL A 247 68.12 -118.64 REMARK 500 MET A 256 31.02 74.66 REMARK 500 GLU A 258 88.62 60.23 REMARK 500 ASN B 155 -22.01 74.91 REMARK 500 ASN B 157 -127.61 51.15 REMARK 500 VAL B 247 73.21 -116.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 586 DISTANCE = 6.52 ANGSTROMS REMARK 525 HOH B 565 DISTANCE = 6.37 ANGSTROMS REMARK 525 HOH B 566 DISTANCE = 6.71 ANGSTROMS REMARK 525 HOH B 567 DISTANCE = 7.17 ANGSTROMS DBREF 7UMW A 1 262 UNP P0AEK4 FABI_ECOLI 1 262 DBREF 7UMW B 1 262 UNP P0AEK4 FABI_ECOLI 1 262 SEQADV 7UMW GLY A -3 UNP P0AEK4 EXPRESSION TAG SEQADV 7UMW ASP A -2 UNP P0AEK4 EXPRESSION TAG SEQADV 7UMW HIS A -1 UNP P0AEK4 EXPRESSION TAG SEQADV 7UMW GLY A 0 UNP P0AEK4 EXPRESSION TAG SEQADV 7UMW GLY B -3 UNP P0AEK4 EXPRESSION TAG SEQADV 7UMW ASP B -2 UNP P0AEK4 EXPRESSION TAG SEQADV 7UMW HIS B -1 UNP P0AEK4 EXPRESSION TAG SEQADV 7UMW GLY B 0 UNP P0AEK4 EXPRESSION TAG SEQRES 1 A 266 GLY ASP HIS GLY MET GLY PHE LEU SER GLY LYS ARG ILE SEQRES 2 A 266 LEU VAL THR GLY VAL ALA SER LYS LEU SER ILE ALA TYR SEQRES 3 A 266 GLY ILE ALA GLN ALA MET HIS ARG GLU GLY ALA GLU LEU SEQRES 4 A 266 ALA PHE THR TYR GLN ASN ASP LYS LEU LYS GLY ARG VAL SEQRES 5 A 266 GLU GLU PHE ALA ALA GLN LEU GLY SER ASP ILE VAL LEU SEQRES 6 A 266 GLN CYS ASP VAL ALA GLU ASP ALA SER ILE ASP THR MET SEQRES 7 A 266 PHE ALA GLU LEU GLY LYS VAL TRP PRO LYS PHE ASP GLY SEQRES 8 A 266 PHE VAL HIS SER ILE GLY PHE ALA PRO GLY ASP GLN LEU SEQRES 9 A 266 ASP GLY ASP TYR VAL ASN ALA VAL THR ARG GLU GLY PHE SEQRES 10 A 266 LYS ILE ALA HIS ASP ILE SER SER TYR SER PHE VAL ALA SEQRES 11 A 266 MET ALA LYS ALA CYS ARG SER MET LEU ASN PRO GLY SER SEQRES 12 A 266 ALA LEU LEU THR LEU SER TYR LEU GLY ALA GLU ARG ALA SEQRES 13 A 266 ILE PRO ASN TYR ASN VAL MET GLY LEU ALA LYS ALA SER SEQRES 14 A 266 LEU GLU ALA ASN VAL ARG TYR MET ALA ASN ALA MET GLY SEQRES 15 A 266 PRO GLU GLY VAL ARG VAL ASN ALA ILE SER ALA GLY PRO SEQRES 16 A 266 ILE ARG THR LEU ALA ALA SER GLY ILE LYS ASP PHE ARG SEQRES 17 A 266 LYS MET LEU ALA HIS CYS GLU ALA VAL THR PRO ILE ARG SEQRES 18 A 266 ARG THR VAL THR ILE GLU ASP VAL GLY ASN SER ALA ALA SEQRES 19 A 266 PHE LEU CYS SER ASP LEU SER ALA GLY ILE SER GLY GLU SEQRES 20 A 266 VAL VAL HIS VAL ASP GLY GLY PHE SER ILE ALA ALA MET SEQRES 21 A 266 ASN GLU LEU GLU LEU LYS SEQRES 1 B 266 GLY ASP HIS GLY MET GLY PHE LEU SER GLY LYS ARG ILE SEQRES 2 B 266 LEU VAL THR GLY VAL ALA SER LYS LEU SER ILE ALA TYR SEQRES 3 B 266 GLY ILE ALA GLN ALA MET HIS ARG GLU GLY ALA GLU LEU SEQRES 4 B 266 ALA PHE THR TYR GLN ASN ASP LYS LEU LYS GLY ARG VAL SEQRES 5 B 266 GLU GLU PHE ALA ALA GLN LEU GLY SER ASP ILE VAL LEU SEQRES 6 B 266 GLN CYS ASP VAL ALA GLU ASP ALA SER ILE ASP THR MET SEQRES 7 B 266 PHE ALA GLU LEU GLY LYS VAL TRP PRO LYS PHE ASP GLY SEQRES 8 B 266 PHE VAL HIS SER ILE GLY PHE ALA PRO GLY ASP GLN LEU SEQRES 9 B 266 ASP GLY ASP TYR VAL ASN ALA VAL THR ARG GLU GLY PHE SEQRES 10 B 266 LYS ILE ALA HIS ASP ILE SER SER TYR SER PHE VAL ALA SEQRES 11 B 266 MET ALA LYS ALA CYS ARG SER MET LEU ASN PRO GLY SER SEQRES 12 B 266 ALA LEU LEU THR LEU SER TYR LEU GLY ALA GLU ARG ALA SEQRES 13 B 266 ILE PRO ASN TYR ASN VAL MET GLY LEU ALA LYS ALA SER SEQRES 14 B 266 LEU GLU ALA ASN VAL ARG TYR MET ALA ASN ALA MET GLY SEQRES 15 B 266 PRO GLU GLY VAL ARG VAL ASN ALA ILE SER ALA GLY PRO SEQRES 16 B 266 ILE ARG THR LEU ALA ALA SER GLY ILE LYS ASP PHE ARG SEQRES 17 B 266 LYS MET LEU ALA HIS CYS GLU ALA VAL THR PRO ILE ARG SEQRES 18 B 266 ARG THR VAL THR ILE GLU ASP VAL GLY ASN SER ALA ALA SEQRES 19 B 266 PHE LEU CYS SER ASP LEU SER ALA GLY ILE SER GLY GLU SEQRES 20 B 266 VAL VAL HIS VAL ASP GLY GLY PHE SER ILE ALA ALA MET SEQRES 21 B 266 ASN GLU LEU GLU LEU LYS HET NAD A 301 44 HET NUC A 302 30 HET NAD B 301 44 HET NUC B 302 30 HETNAM NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE HETNAM NUC (2E)-3-[(7S)-7-AMINO-8-OXO-6,7,8,9-TETRAHYDRO-5H- HETNAM 2 NUC PYRIDO[2,3-B]AZEPIN-3-YL]-N-METHYL-N-[(3-METHYL-1- HETNAM 3 NUC BENZOFURAN-2-YL)METHYL]PROP-2-ENAMIDE FORMUL 3 NAD 2(C21 H27 N7 O14 P2) FORMUL 4 NUC 2(C23 H24 N4 O3) FORMUL 7 HOH *353(H2 O) HELIX 1 AA1 SER A 19 GLU A 31 1 13 HELIX 2 AA2 ASN A 41 LEU A 55 1 15 HELIX 3 AA3 GLU A 67 LYS A 80 1 14 HELIX 4 AA4 PRO A 96 ASP A 101 5 6 HELIX 5 AA5 ASP A 103 VAL A 108 1 6 HELIX 6 AA6 THR A 109 SER A 121 1 13 HELIX 7 AA7 SER A 121 ARG A 132 1 12 HELIX 8 AA8 TYR A 146 GLU A 150 5 5 HELIX 9 AA9 ASN A 157 GLY A 178 1 22 HELIX 10 AB1 THR A 194 SER A 198 5 5 HELIX 11 AB2 ASP A 202 THR A 214 1 13 HELIX 12 AB3 THR A 221 CYS A 233 1 13 HELIX 13 AB4 SER A 234 ALA A 238 5 5 HELIX 14 AB5 GLY A 250 ALA A 254 5 5 HELIX 15 AB6 SER B 19 GLU B 31 1 13 HELIX 16 AB7 ASN B 41 LYS B 43 5 3 HELIX 17 AB8 LEU B 44 LEU B 55 1 12 HELIX 18 AB9 GLU B 67 LYS B 80 1 14 HELIX 19 AC1 PRO B 96 ASP B 101 5 6 HELIX 20 AC2 ASP B 103 VAL B 108 1 6 HELIX 21 AC3 THR B 109 SER B 121 1 13 HELIX 22 AC4 SER B 121 ARG B 132 1 12 HELIX 23 AC5 SER B 133 LEU B 135 5 3 HELIX 24 AC6 TYR B 146 GLU B 150 5 5 HELIX 25 AC7 ASN B 157 GLY B 178 1 22 HELIX 26 AC8 THR B 194 SER B 198 5 5 HELIX 27 AC9 ASP B 202 THR B 214 1 13 HELIX 28 AD1 THR B 221 CYS B 233 1 13 HELIX 29 AD2 SER B 234 ALA B 238 5 5 HELIX 30 AD3 GLY B 250 ALA B 254 5 5 SHEET 1 AA1 7 VAL A 60 GLN A 62 0 SHEET 2 AA1 7 GLU A 34 TYR A 39 1 N PHE A 37 O LEU A 61 SHEET 3 AA1 7 ARG A 8 VAL A 11 1 N VAL A 11 O ALA A 36 SHEET 4 AA1 7 PHE A 85 HIS A 90 1 O VAL A 89 N LEU A 10 SHEET 5 AA1 7 LEU A 135 SER A 145 1 O LEU A 142 N HIS A 90 SHEET 6 AA1 7 VAL A 182 ALA A 189 1 O ILE A 187 N SER A 145 SHEET 7 AA1 7 VAL A 244 VAL A 247 1 O VAL A 245 N ALA A 186 SHEET 1 AA2 7 VAL B 60 GLN B 62 0 SHEET 2 AA2 7 GLU B 34 TYR B 39 1 N PHE B 37 O LEU B 61 SHEET 3 AA2 7 ARG B 8 VAL B 11 1 N VAL B 11 O ALA B 36 SHEET 4 AA2 7 PHE B 88 HIS B 90 1 O VAL B 89 N LEU B 10 SHEET 5 AA2 7 SER B 139 SER B 145 1 O LEU B 142 N HIS B 90 SHEET 6 AA2 7 VAL B 182 ALA B 189 1 O ILE B 187 N SER B 145 SHEET 7 AA2 7 VAL B 244 VAL B 247 1 O VAL B 245 N ALA B 186 CRYST1 79.540 79.540 323.680 90.00 90.00 120.00 P 61 2 2 24 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012572 0.007259 0.000000 0.00000 SCALE2 0.000000 0.014517 0.000000 0.00000 SCALE3 0.000000 0.000000 0.003089 0.00000